2024. 10. 09
New C2H Report: Ropeginterferon Alfa-2b (Besremi)
New C2H Report: Ensitrelvir (Xocova)
2024. 09. 11
New C2H Report: Tirzepatide (Mounjaro)
View all news
2019. 03. 06
International symposium - Current status and future role of HTA in Japan and other countries
View all events
View all reports